Early Versus Late Administration of P2Y12 Inhibitors in Non-ST Segment Elevation Myocardial Infarction and Delayed Cardiac Catheterization

被引:0
|
作者
Lycouras, Maggie M. [1 ]
Clark, Collin M. [1 ,2 ]
Mills, Kevin [1 ]
Gupta, Aman [3 ]
Chilbert, Maya R. [1 ,2 ]
机构
[1] Buffalo Gen Med Ctr, Pharm Dept, Buffalo, NY USA
[2] Univ Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[3] Buffalo Gen Med Ctr, Cardiol Dept, Buffalo, NY USA
关键词
P2Y(12) inhibitors; NSTEMI; GP IIb; IIIa inhibitor; bleeding; troponin; METAANALYSIS; ANGIOGRAPHY; ANTAGONISTS; DEFINITION; RISK;
D O I
10.1097/FJC.0000000000001302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regardless of early invasive or ischemia-guided approaches to non-ST segment elevation myocardial infarction (NSTEMI) management, P2Y(12) inhibitors remain the backbone in therapy. The ideal timing of administration remains unclear. The purpose of this study was to determine the safety and effectiveness of early versus late administration of P2Y(12) inhibitors in patients presenting with an NSTEMI who go to the catheterization laboratory beyond 24 hours from presentation. We performed a single center, retrospective cohort study. Patients were classified into groups depending on whether they received early versus late administration of a P2Y(12) inhibitor. The primary outcome was the rate of major and clinically relevant, nonmajor bleeding (CRNMB). Secondary outcomes included troponin peak and length of stay after cardiac catheterization. Of the 121 patients included, 53 patients were in the early and 68 patients were in the late group. The number of bleeding events were similar between both groups (P = 1.00). There were 3 (5.7%) major bleeding events in the early group and 5 (7.4%) bleeding events in the late group. There were 5 (9.4%) CRNMB events in the early group and 6 (8.8%) CRNMB events in the late group. There was a significant difference in troponin peak, 4.56 ng/mL in the early group and 1.77 ng/mL in the late group (P = 0.02). The rate of bleeding did not differ between patients who received early or late administration of P2Y(12) inhibitors for NSTEMI management who undergo delayed cardiac catheterization.
引用
收藏
页码:270 / 275
页数:6
相关论文
共 50 条
  • [21] Impact of oral P2Y12 inhibitors on residual thrombus burden and reperfusion indexes in patients with ST-segment elevation myocardial infarction
    Di Vito, Luca
    Versaci, Francesco
    Limbruno, Ugo
    Pawlowski, Tomasz
    Gatto, Laura
    Romagnoli, Enrico
    Cattabiani, Maria Alberta
    Micari, Antonio
    Trivisonno, Antonio
    Marco, Valeria
    Prati, Francesco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (09) : 701 - 706
  • [22] Pretreatment with P2Y12 inhibitors and outcome in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention
    Gach, Olivier
    Nyssen, Astrid
    Pirlet, Charles
    Magne, Julien
    Oury, Cecile
    Lancellotti, Patrizio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (05) : 234 - 239
  • [23] Management of myocardial infarction with ST-segment elevation in a patient with aspirin hypersensitivity without the use of oral P2Y12 receptor inhibitors
    Bianco, Matteo
    Biole, Carloalberto
    Spirito, Amanda
    Destefanis, Paola
    Luciano, Alessia
    Montagna, Laura
    Cerrato, Enrico
    GIORNALE ITALIANO DI CARDIOLOGIA, 2022, 23 (01) : 75 - 77
  • [25] Early versus delayed coronary artery bypass graft surgery for patients with non-ST elevation myocardial infarction
    Ha, Le Dung
    Ogunbayo, Gbolahan
    Elbadawi, Ayman
    Olorunfemi, Odunayo
    Messerli, Adrian
    CORONARY ARTERY DISEASE, 2017, 28 (08) : 670 - 674
  • [26] Non-ST Segment Elevation Myocardial Infarction in Patients Admitted With Sepsis: A Comparison of Ischemia-Guided Strategy and Early Catheterization
    Alhalaseh, Saleh
    Alziadin, Nmair
    Maraey, Ahmed
    Raju, Apoorva T.
    Mann, Sabrina A.
    Alwarawrah, Zaid
    Al Wahadneh, Omar
    CIRCULATION, 2023, 148
  • [27] Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction
    Cannon, CP
    CORONARY ARTERY DISEASE, 1999, 10 (08) : 561 - 566
  • [28] EARLY VERSUS DELAYED INVASIVE INTERVENTION FOR NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS OLDER THAN 80 YEARS: A NATIONWIDE ANALYSIS
    Lemor, Alejandro
    Dominguez, Abel Casso
    Lee, Shawn
    Gongora, Carlos
    Gholitabar, Farid
    Metha, Davendra
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1091 - 1091
  • [29] Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: A systematic review and meta-analysis
    Gewehr, Douglas Mesadri
    Carvalho, Pedro Emanuel de Paula
    Dagostin, Caroline Serafim
    Cardoso, Rhanderson
    Kubrusly, Taiane Belinati Loureiro
    Kubrusly, Fernando Bermudez
    Kubrusly, Luiz Fernando
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2023, 102 (02) : 200 - 211
  • [30] Pretreatment With P2Y12 Inhibitors in ST-Elevation Myocardial Infarction & Systematic Review and Meta-Analysis
    Gewehr, Douglas Mesadri
    Dagostin, Caroline
    Cardoso, Rhanderson
    Kubrusly, Taiane B.
    Kubrusly, Fernando B.
    Kubrusly, Luiz F.
    CIRCULATION, 2022, 146